Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.
To help clinicians stay current on orthopaedic and musculoskeletal research, Wolters Kluwer, Health announced today that Ovid® users will now have access to OrthoEvidence, a first of its kind evidence-based summary provider for orthopaedic specialists, surgeons, nurses, medical residents and students.
NEJM Group and Education Management Solutions (EMS), a Collegis Education company, have signed an agreement to put a cutting-edge clinical diagnosis training program in front of every healthcare student in the United States.
EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.
Thirty-three inventors from two colleges, six departments and three research centers at The University of Alabama in Huntsville (UAH), a part of the University of Alabama System, received award plaques for 21 patents at a virtual ceremony on Friday, April 16.
Corporations concerned with cultivating and recruiting the workforce of tomorrow due to the dramatic effects of COVID-19 on America’s youth are turning to CFES Brilliant Pathways for answers.
Wolters Kluwer, Health, a leading global provider of information and point-of-care solutions for the healthcare industry, is pleased to announce that it has been named publisher of American Journal of Medical Quality (AJMQ), the official journal of the American College of Medical Quality (ACMQ).
Rodeo Therapeutics Corp., a drug-development startup founded by two leading researchers from the Case Western Reserve University School of Medicine and a third scientific partner, has been sold to Amgen Inc., a publicly traded international biopharmaceutical company. Under terms of the agreement, Amgen, based in Thousand Oaks, California, will acquire all outstanding shares of Rodeo for $55 million, plus “future contingent milestone payments potentially worth up to an additional $666 million in cash,” the companies announced today. Total consideration to Rodeo stakeholders could potentially be worth up to $721 million in cash.
Electronics so pretty they could hang on your wall.
GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Ambry Genetics®, a leading clinical genetic testing company, to integrate online genetic counseling and testing services into gastroenterology practices nationwide. This partnership addresses a critical clinical need for identifying hereditary GI cancer syndromes to help guide potentially life-altering health care decisions. GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer the CARE (Comprehensive, Assessment, Risk, and Education) Program™ from Ambry Genetics.
RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of a third-party test that proves the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.96% of airborne SARS-CoV-2 virus.
La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates.
Case Western Reserve University’s HoloAnatomy® Software Suite will star this week in online events that Microsoft is hosting for colleges and universities-- Tuesday, Jan. 26, in a webinar titled “A New Vision for Medical Education” and Wednesday, Jan. 27, in Microsoft’s HoloLens Industry Summit, which will include an education break-out session.
Today, Wolters Kluwer, Health announced the publication of Cannabis: A Handbook for Nurses, the first medical cannabis book written specifically for nurses. The book addresses nursing skills and responsibilities in cannabis care, including the physiology of the human endocannabinoid system, cannabis care as it relates to specific disease processes, the history of cannabis, advocacy and ethics, and the ins and outs of cannabis dosing, delivery methods, side effects, and more.
Ames Laboratory will partner with Electron Energy Corporation to improve a mainstay of magnet technology-- the samarium cobalt (SmCo) magnet.
Arthrex, a global leader in minimally invasive orthopedic technology, announced today the launch of the SwiveLock® ACL Repair Kit, following clearance by the U.S. Food and Drug Administration of the SwiveLock® anchor for ACL repair. It is the first and only FDA-cleared kit for the primary repair of anterior cruciate ligament (ACL) tears.
ALCEDIAG, one of 3 finalists for the “Disruptive Technology Award” at the annual AACC meeting 2020, will be holding a press conference to announce a game-changing technology and diagnostic tool for precision medicine in psychiatry: EDIT-BTM, the very first blood test for a high-performance differential diagnosis of unipolar depression and bipolar disorder.
AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.
Join us for an overview of MedSchenker’s product lines, including our Smart Transport Medium (STM™) and CavSwabs, among other innovations we introduced to the market this past year.
GenScript USA Inc., the world’s leading research reagent provider, announced today that Brazil's National Health Surveillance Agency (ANVISA) (Agência Nacional de Vigilância Sanitária) has authorized the use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit for detecting neutralizing antibodies. The cPass test is the first and only ANVISA authorized test for detecting neutralizing antibodies to SARS-CoV-2. Neutralizing antibodies specifically block the ability of a virus to infect a cell and are well-recognized to confer immunity.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right